Leanne M. Kelly
CFO & Corporate SecretaryMs. Leanne M. Kelly is Chief Financial Officer of GRI Bio, Inc. from April 20, 2023 and serves as its Corporate Secretary. She served as the Chief Financial Officer at Vallon Pharmaceuticals, Inc. since May 10, 2021. She had been an Independent Director of Windtree Therapeutics, Inc. since January 2025 until July 29, 2025. She is an accomplished financial executive with experience leading private and publicly traded companies across life science, technology and e-Commerce sectors and a foundation in public accounting. She served as the Controller and Executive Director, Global Financial Reporting at OptiNose, Inc. from September 2016 to May 2021. Over the course of her career, she has held Senior Vice President of Finance, Controller and Chief Financial Officer positions in private and public companies such as Flower Orthopedics, Iroko Pharmaceuticals, LLC. She also has experience in financial oversight, internal and external financial reporting, forecasting and financial analysis, as well as Investor and public relations. From February 2016 to September 2016, she served as a senior Manager at Genova Group, a financial advisory and support consulting firm. From September 2013 to January 2016, she served as Senior Vice President of Finance of Flower Orthopedics Corporation, a private medical device company. She has also served as Controller of Iroko Pharmaceuticals, LLC in 2013. She served as the Chief Financial Officer and Senior Vice President at Genaera Corporation since 2002 until 2009 and also served as its Executive Director of Finance since July 2004. Ms. Kelly served as Principal Accounting Officer, Controller and Secretary of Genaera Corp. She served as Interim Chief Financial Officer of Genaera Corp. since August 22, 2003, Vice President, Finance since January 2006 and Controller since December 2002. Ms. Kelly has a solid background in accounting and SEC reporting with development-stage technology companies. She served as Controller of Lamina Ceramics, Inc. She also served as Senior Financial Analyst and SEC Accountant at Luminant Worldwide Corporation and Senior Auditor with KPMG LLP. Ms. Kelly holds a Certified Public Accountant (inactive status) certificate from the Pennsylvania State Board of Accountancy and is a Member of the Pennsylvania Institute of Certified Public Accountants. Ms. Kelly received her Bachelor of Science degree in Business Economics with a concentration in Accounting from Lehigh University. She is a licensed CPA (inactive status) in the state of Pennsylvania.
Positions
- Company NameGRI Bio, Inc.Stock CodeGRIPositionCFO & Corporate SecretaryColleagues
- WMW. Marc HertzCo-Founder, CEO, President & Director
- DLDavid L. SzekeresIndependent Chairman of the Board
- VKVipin Kumar ChaturvediCo-Founder & Chief Scientific Officer
- AAAlbert AgroCo-Founder & Chief Medical Officer
- RRRoelof RongenIndependent Director
- CVCamilla V. SimpsonIndependent Director
- DCDavid Charles BakerDirector
